News search

E.g., 13/12/2025
E.g., 13/12/2025
Protection against blood vessel occlusion in animals with sickle cell anemia after treatment with circadian clock inhibitors. Vessel walls are shown as white lines, neutrophils in yellow, and red blood cells trapped by neutrophils in red.
Research
12 Dec 2025

A CNIC study reveals that neutrophils—a type of immune cell—are less aggressive at night, explaining why nighttime heart attacks are less severe than those occurring during the day

Dos proyectos del CNIC seleccionados en la convocatoria Investigación en Salud 2025 de la Fundación ”la Caixa”
About the CNIC
20 Nov 2025

In this latest round, the la Caixa Foundation Health Research Call has selected 34 new cutting-edge biomedical research projects

Edgar Gomes
Sabrina Molinaro
JACARDI_Madrid
About the CNIC
20 Oct 2025

The Spanish National Center for Cardiovascular Research (CNIC) hosted in Madrid the third General Assembly of JACARDI from October 14 to 16 

Luca Scorrano, M.D., Ph.D., is a Professor of Biochemistry at Padova University Medical School (Italy)
José Luis de la Pompa, Blanca Rubio, Rocío Serrano, Laura Lalaguna, Pablo García Pavía, María López Olañeta y Enrique Lara.
Research
10 Sep 2025

The results, published in the European Heart Journal and presented at the European Society of Cardiology Congress, opens the way to new therapies for patients with genetic heart diseases

Pablo García-Pavía, Nerea Mora Ayestarán y Fernando Domínguez
Research
3 Sep 2025

Scientists at the Centro Nacional de Investigaciones Cardiovasculares (CNIC), together with cardiologists from Hospital Universitario Puerta de Hierro and the Spanish cardiovascular disease research network (CIBERCV), report that the new discovery makes it possible to identify high-risk patients early and refer them sooner to specialized heart failure units

CNIC-led REBOOT clinical trial challenges 40-year-old standard of care for heart attack patients
Research
30 Aug 2025

REBOOT trial, coordinated by the CNIC, shows that treatment with beta-blockers provides no benefit to patients who experience an uncomplicated heart attack that leaves the contractile function of the heart intact.